Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses

Journal of the American Veterinary Medical Association

Volumn 213, Issue 7, 1998, Pages 1007-1011

  Magdesian, K Gary ^a,c   Hogan, Patricia M ^a,d   Cohen, Noah D ^a   Brumbaugh, Gordon W ^a   Bernard, William V ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b ROOD AND RIDDLE EQUINE HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d New Jersey Equine Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ANIMAL CELL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SCREENING; HORSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0031726538     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.1998.213.07.1007     Document Type: Article

References (25)

1. Prescott JF, Baggot JD. Antimicrobial therapy in veterinary medicine. 2nd ed. Ames, Iowa: Iowa State University Press, 1993;144-178.
2. Zhanel GC, Pharm D, Ariano RE. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity? Ren Fail 1992;14:1-9.
3. Moore RD, Lietman PS, Smith CR. Clinical response to amino-glycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99.
4. Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 1984;149:443-448.
5. Kapusnik JE, Hackbarth CJ, Chambers HF, et al. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. J Inject Dis 1988;158:7-12.
6. Godber LM, Walker RD, Stein GE, et al. Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. Am J Vet Res 1995;56:613-618.
7. Golenz MR, Wilson WD, Carlson GP, et al. Effect of route of administration and age on the pharmacokinetics of amikacin administered by the intravenous and intraosseous routes to 3 and 5-day-old foals. Equine Vet J 1994;26:367-373.
8. Green SL, Conlon PD, Mama K, et al. Effects of hypoxaemia and azotaemia on the pharmacokinetics of amikacin in neonatal foals. Equine Vet J 1992;24:475-479.
9. Schumacher J, Wilson RC, Spano JS, et al. Effect of diet on gentamicin-induced nephrotoxicosis in horses. Am J Vet Res 1991;52: 1274-1278.
10. Easter JL, Hague BA, Brumbaugh GW, et al. Effects of post-operative peritoneal lavage on pharmacokinetics of gentamicin in horses after cehotomy. Am J Vet Res 1997;58:1166-1170.
11. Skopnik H, Wallraf R, Nies B, et al. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child 1992;67: 57-61.
12. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, ed. Antibiotics in laboratory medicine. 2nd ed. Baltimore: The Williams & Wilkins Co, 1986;515-535.
13. Bundtzen RW, Gerber AU, Cohn DL, et al. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981;3:28-37.
14. Winstanley TG, Hastings JGM. Penicillin-aminoglycoside synergy and post-antibiotic effect for enterococci. J Antimicrob Chemother 1989;23:189-199.
15. Watling SM, Dasta JF. Aminoglycoside dosing considerations in intensive care unit patients. Ann Pharmacother 1993;27: 351-355.
16. Sojka JE, Brown SA. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. J Am Vet Med Assoc 1986; 189: 784-789.
17. Adamson PJ, Wilson WD, Hirsh DC, et al. Susceptibility of equine bacterial isolates to antimicrobial agents. Am J Vet Res 1985; 46:447-450.
18. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341:335-339.
19. Nordstrom L, Ringberg H, Cronberg S, et al. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother 1990;25:159-173.
20. Verpooten GA, Giuliano RA, Verbist L, et al. Once daily dosing decreases accumulation of gentamicin and netilmicin. Clin Pharm Ther 1989;45:22-27.
21. Gilman JM, Davis LE, Neff-Davis CA, et al. Plasma concentration of gentamicin after intramuscular or subcutaneous administration to horses. J Vet Pharmacol Ther 1987;10:101-103.
22. Sweeney RW, Divers TJ, Rossier Y. Disposition of gentamicin administered intravenously to horses with sepsis. J Am Vet Med Assoc 1992;200:503-506.
23. Pederlosi WM, Belmonte AA, Purohit RC, et al. Pharmacokinetics of gentamicin in the horse. Am J Vet Res 1980;41:351-354.
24. Bowman KF, Dix LP, Riond JL, et al. Prediction of pharmacokinetic profiles of ampicillin sodium, gentamicin sulfate, and combination ampicillin sodium-gentamicin sulfate in serum and synovia of healthy horses. Am J Vet Res 1986;47:1590-1596.
25. Brumbaugh GW. Antimicrobial susceptibility and therapy: concepts and controversies, parts I & II, in Proceedings. 8th Annu Am Coll Vet Intern Med Forum 1990;525-532.